Overview
We aim to improve early cancer detection using liquid biopsy, with a current focus on breast, ovarian and lung cancers. We have collected longitudinal blood samples from people at high risk of developing these cancers, and are developing a range of techniques to detect circulating tumour DNA (ctDNA) to detect cancer at an earlier stage and improve prognosis.